COSCIENS Biopharma (CSCI) Revenue

Annual Revenue

$7.26 M
-$6.62 M-47.69%

December 1, 2023

Summary

Performance

1-Year Change

-47.69%

3-Year Change

-38.76%

5-Year Change

-14.68%

15-Year Change

-29.35%

CSCI Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.44%
CSCI annual revenue is higher than 26.44% of companies in Healthcare sector

Analysts Estimate

$4.30 M
CSCI annual revenue is currently +68.88% higher than the consensus analysts' forecast

High & Low

All-time High

$13.88 M
CSCI annual revenue is currently -47.69% below its historical high of $13.88 million

3-Year Low

$7.26 M
CSCI annual revenue is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
CSCI previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
CSCI next annual earnings announcement has not yet been scheduled

OtherCSCIprofitabilitymetrics:

Annual EPS

-$1.92
CSCI annual earnings per share is -$1.92

Annual Net Income

-$3.55 M
CSCI annual net profit is -$3.55 million

Annual Operating Profit

-$18.01 M
CSCI annual operating income is -$18.01 million

Annual Gross Profit

$2.93 M
CSCI annual gross profit is $2.93 million

Quarterly Revenue

$1.87 M
-$466.00 K-19.94%

September 1, 2024

Summary

Performance

3-Month Change

-19.94%

1-Year Change

+40.39%

3-Year Change

+40.39%

5-Year Change

+40.39%

CSCI Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

22.26%
CSCI quarterly revenue is higher than 22.26% of companies in Healthcare sector

High & Low

All-time High

$4.94 M
CSCI quarterly revenue is currently -62.15% below its historical high of $4.94 million

3-Year Low

$1.33 M
CSCI quarterly revenue is currently +40.39% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CSCI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
CSCI next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

$957.00 K
CSCI quarterly gross profit is $957.00 thousand

Quarterly Operating Profit

-$4.83 M
CSCI quarterly operating income is -$4.83 million

Quarterly Net Income

-$5.75 M
CSCI quarterly net profit is -$5.75 million

Quarterly EPS

-$1.85
CSCI quarterly earnings per share is -$1.85

TTM Revenue

$7.59 M
-$81.00 K-1.06%

September 1, 2024

Summary

Performance

3-Month Change

-1.06%

1-Year Change

+4.59%

3-Year Change

+4.59%

5-Year Change

+4.59%

CSCI TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

21.28%
CSCI TTM revenue is higher than 21.28% of companies in Healthcare sector

High & Low

All-time High

$15.56 M
CSCI TTM revenue is currently -51.19% below its historical high of $15.56 million

3-Year Low

$6.73 M
CSCI TTM revenue is currently +12.84% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CSCI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
CSCI next earnings announcement has not yet been scheduled

OtherCSCIprofitabilitymetrics:

TTM Gross Profit

$2.87 M
CSCI TTM gross profit is $2.87 million

TTM Operating Profit

-$12.52 M
CSCI TTM operating income is -$12.52 million

TTM Net Income

-$10.21 M
CSCI TTM net profit is -$10.21 million

TTM EPS

-$3.99
CSCI TTM earnings per share is -$3.99

CSCI Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-47.7%+40.4%+4.6%
3 y3 years-38.8%+40.4%+4.6%
5 y5 years-14.7%+40.4%+4.6%

CSCI Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-47.7%at low-62.1%+40.4%-51.2%+12.8%
5 y5-year-47.7%at low-62.1%+40.4%-51.2%+12.8%
alltimeall time-47.7%+3123.1%-62.1%>+9999.0%-51.2%+3744.8%

COSCIENS Biopharma Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.87 M(-19.9%)
$7.59 M(-1.1%)
Jun 2024
-
$2.34 M(+13.8%)
$7.67 M(+14.0%)
Mar 2024
-
$2.05 M(+54.0%)
$6.73 M(-7.3%)
Dec 2023
$7.26 M(-47.7%)
$1.33 M(-31.7%)
$7.26 M(-14.2%)
Sep 2023
-
$1.95 M(+40.2%)
$8.46 M(-9.2%)
Jun 2023
-
$1.39 M(-46.1%)
$9.32 M(-23.6%)
Mar 2023
-
$2.58 M(+1.9%)
$12.20 M(-16.2%)
Dec 2022
$13.88 M(+2.9%)
$2.53 M(-9.9%)
$14.56 M(-1.8%)
Sep 2022
-
$2.81 M(-34.1%)
$14.82 M(-4.7%)
Jun 2022
-
$4.27 M(-13.6%)
$15.56 M(+4.8%)
Mar 2022
-
$4.94 M(+76.7%)
$14.84 M(+8.9%)
Dec 2021
$13.49 M(+13.7%)
$2.80 M(-21.1%)
$13.62 M(+1.6%)
Sep 2021
-
$3.55 M(-0.3%)
$13.41 M(+7.6%)
Jun 2021
-
$3.56 M(-4.5%)
$12.46 M(+1.1%)
Mar 2021
-
$3.72 M(+44.2%)
$12.32 M(+6.1%)
Dec 2020
$11.86 M(+20.3%)
$2.58 M(-0.5%)
$11.61 M(-3.0%)
Sep 2020
-
$2.60 M(-24.0%)
$11.97 M(+3.5%)
Jun 2020
-
$3.42 M(+13.4%)
$11.57 M(+10.4%)
Mar 2020
-
$3.01 M(+2.4%)
$10.48 M(+6.3%)
Dec 2019
$9.86 M(+15.8%)
$2.94 M(+33.9%)
$9.86 M(-0.6%)
Sep 2019
-
$2.20 M(-5.6%)
$9.91 M(+5.9%)
Jun 2019
-
$2.33 M(-2.8%)
$9.36 M(+2.7%)
Mar 2019
-
$2.39 M(-20.1%)
$9.11 M(+7.5%)
Dec 2018
$8.51 M(-17.2%)
$3.00 M(+82.2%)
$8.47 M(+9.6%)
Sep 2018
-
$1.64 M(-20.8%)
$7.73 M(-14.0%)
Jun 2018
-
$2.08 M(+18.2%)
$8.99 M(-3.9%)
Mar 2018
-
$1.76 M(-22.0%)
$9.35 M(-6.3%)
Dec 2017
$10.28 M(+1.0%)
$2.25 M(-22.4%)
$9.98 M(+6.8%)
Sep 2017
-
$2.90 M(+18.9%)
$9.35 M(+6.9%)
Jun 2017
-
$2.44 M(+2.2%)
$8.74 M(-8.2%)
Mar 2017
-
$2.39 M(+47.6%)
$9.52 M(-7.2%)
Dec 2016
$10.17 M(+32.3%)
$1.62 M(-29.5%)
$10.26 M(-6.2%)
Sep 2016
-
$2.30 M(-28.8%)
$10.95 M(+0.0%)
Jun 2016
-
$3.22 M(+2.9%)
$10.95 M(+13.0%)
Mar 2016
-
$3.13 M(+36.1%)
$9.69 M(+22.5%)
Dec 2015
$7.69 M(+0.4%)
$2.30 M(+0.3%)
$7.91 M(+10.6%)
Sep 2015
-
$2.29 M(+16.7%)
$7.15 M(+1.5%)
Jun 2015
-
$1.97 M(+45.3%)
$7.05 M(-4.3%)
Mar 2015
-
$1.35 M(-12.1%)
$7.36 M(-5.3%)
Dec 2014
$7.66 M(+25.0%)
$1.54 M(-29.8%)
$7.78 M(+3.7%)
Sep 2014
-
$2.19 M(-3.9%)
$7.50 M(+3.5%)
Jun 2014
-
$2.28 M(+28.9%)
$7.24 M(+22.2%)
Mar 2014
-
$1.77 M(+40.4%)
$5.93 M(-3.4%)
Dec 2013
$6.13 M(+18.0%)
$1.26 M(-35.0%)
$6.14 M(+1.5%)
Sep 2013
-
$1.94 M(+101.3%)
$6.04 M(+11.7%)
Jun 2013
-
$962.10 K(-51.4%)
$5.41 M(-8.5%)
Mar 2013
-
$1.98 M(+69.6%)
$5.91 M(+15.3%)
Dec 2012
$5.19 M(-8.4%)
$1.17 M(-10.6%)
$5.13 M(-7.6%)
Sep 2012
-
$1.30 M(-11.0%)
$5.55 M(-2.7%)
Jun 2012
-
$1.47 M(+22.9%)
$5.70 M(+4.4%)
Mar 2012
-
$1.19 M(-24.9%)
$5.46 M(-6.6%)
Dec 2011
$5.67 M(+1.6%)
$1.59 M(+8.7%)
$5.85 M(-3.7%)
Sep 2011
-
$1.46 M(+19.3%)
$6.08 M(-3.1%)
Jun 2011
-
$1.22 M(-22.4%)
$6.27 M(+4.3%)
Mar 2011
-
$1.58 M(-13.0%)
$6.01 M(+8.0%)
Dec 2010
$5.58 M
$1.81 M(+9.6%)
$5.57 M(+32.3%)
DateAnnualQuarterlyTTM
Sep 2010
-
$1.66 M(+71.3%)
$4.21 M(+12.7%)
Jun 2010
-
$966.20 K(-14.7%)
$3.73 M(-2.0%)
Mar 2010
-
$1.13 M(+149.4%)
$3.81 M(-1.5%)
Dec 2009
$4.17 M(+20.1%)
$454.20 K(-61.5%)
$3.87 M(-0.4%)
Sep 2009
-
$1.18 M(+13.1%)
$3.88 M(+10.1%)
Jun 2009
-
$1.04 M(-12.2%)
$3.53 M(-9.9%)
Mar 2009
-
$1.19 M(+152.4%)
$3.91 M(+10.2%)
Dec 2008
$3.47 M(-0.2%)
$471.20 K(-42.8%)
$3.55 M(-8.3%)
Sep 2008
-
$823.10 K(-42.4%)
$3.87 M(+6.3%)
Jun 2008
-
$1.43 M(+72.8%)
$3.64 M(+11.6%)
Mar 2008
-
$827.70 K(+4.6%)
$3.26 M(-0.2%)
Dec 2007
$3.48 M(+22.6%)
$791.20 K(+33.0%)
$3.27 M(+9.6%)
Sep 2007
-
$595.00 K(-43.4%)
$2.98 M(-2.9%)
Jun 2007
-
$1.05 M(+26.1%)
$3.07 M(+7.1%)
Mar 2007
-
$833.60 K(+64.9%)
$2.87 M(+2.2%)
Dec 2006
$2.84 M(+22.9%)
$505.60 K(-25.9%)
$2.81 M(-0.7%)
Sep 2006
-
$682.70 K(-19.5%)
$2.83 M(+4.4%)
Jun 2006
-
$848.20 K(+10.0%)
$2.71 M(+0.2%)
Mar 2006
-
$771.30 K(+46.6%)
$2.70 M(+20.0%)
Dec 2005
$2.31 M(+41.9%)
$526.30 K(-6.5%)
$2.25 M(+10.4%)
Sep 2005
-
$562.60 K(-33.2%)
$2.04 M(+16.3%)
Jun 2005
-
$842.30 K(+162.2%)
$1.75 M(+19.1%)
Mar 2005
-
$321.20 K(+2.5%)
$1.47 M(-6.8%)
Dec 2004
$1.63 M(-4.8%)
$313.50 K(+13.3%)
$1.58 M(-10.4%)
Sep 2004
-
$276.80 K(-50.6%)
$1.76 M(-4.2%)
Jun 2004
-
$560.50 K(+30.9%)
$1.84 M(-1.1%)
Mar 2004
-
$428.10 K(-13.9%)
$1.86 M(+10.0%)
Dec 2003
$1.71 M(+81.1%)
$497.10 K(+40.7%)
$1.69 M(+22.6%)
Sep 2003
-
$353.30 K(-39.3%)
$1.38 M(+10.9%)
Jun 2003
-
$581.70 K(+124.9%)
$1.24 M(+13.5%)
Mar 2003
-
$258.60 K(+39.6%)
$1.10 M(+13.7%)
Dec 2002
$944.70 K(+30.8%)
$185.20 K(-14.8%)
$963.30 K(+2.9%)
Sep 2002
-
$217.40 K(-49.9%)
$936.10 K(-5.3%)
Jun 2002
-
$434.30 K(+243.6%)
$988.90 K(+35.0%)
Mar 2002
-
$126.40 K(-20.0%)
$732.50 K(+0.4%)
Dec 2001
$722.00 K(+33.9%)
$158.00 K(-41.5%)
$729.30 K(+23.6%)
Sep 2001
-
$270.20 K(+51.9%)
$589.90 K(-8.0%)
Jun 2001
-
$177.90 K(+44.4%)
$640.90 K(+7.2%)
Mar 2001
-
$123.20 K(+562.4%)
$598.00 K(+10.0%)
Dec 2000
$539.40 K(+139.4%)
$18.60 K(-94.2%)
$543.60 K(-0.5%)
Sep 2000
-
$321.20 K(+137.9%)
$546.20 K(+27.2%)
Jun 2000
-
$135.00 K(+96.2%)
$429.30 K(+18.6%)
Mar 2000
-
$68.80 K(+224.5%)
$362.10 K(+0.7%)
Dec 1999
$225.30 K(-13.3%)
$21.20 K(-89.6%)
$359.60 K(+6.9%)
Sep 1999
-
$204.30 K(+201.3%)
$336.30 K(+70.3%)
Jun 1999
-
$67.80 K(+2.3%)
$197.50 K(-50.9%)
Mar 1999
-
$66.30 K(-3257.1%)
$402.00 K(-1.0%)
Dec 1998
$260.00 K(-83.8%)
-$2100.00(-103.2%)
$406.10 K(-56.3%)
Sep 1998
-
$65.50 K(-75.9%)
$929.60 K(-32.2%)
Jun 1998
-
$272.30 K(+286.8%)
$1.37 M(-1.3%)
Mar 1998
-
$70.40 K(-86.5%)
$1.39 M(-17.4%)
Dec 1997
$1.61 M(+267.1%)
$521.40 K(+2.9%)
$1.68 M(+45.0%)
Sep 1997
-
$506.70 K(+74.9%)
$1.16 M(+77.7%)
Jun 1997
-
$289.70 K(-20.0%)
$652.00 K(+80.0%)
Mar 1997
-
$362.30 K
$362.30 K
Dec 1996
$437.80 K
-
-

FAQ

  • What is COSCIENS Biopharma annual revenue?
  • What is the all time high annual revenue for COSCIENS Biopharma?
  • What is COSCIENS Biopharma annual revenue year-on-year change?
  • What is COSCIENS Biopharma quarterly revenue?
  • What is the all time high quarterly revenue for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly revenue year-on-year change?
  • What is COSCIENS Biopharma TTM revenue?
  • What is the all time high TTM revenue for COSCIENS Biopharma?
  • What is COSCIENS Biopharma TTM revenue year-on-year change?

What is COSCIENS Biopharma annual revenue?

The current annual revenue of CSCI is $7.26 M

What is the all time high annual revenue for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual revenue is $13.88 M

What is COSCIENS Biopharma annual revenue year-on-year change?

Over the past year, CSCI annual revenue has changed by -$6.62 M (-47.69%)

What is COSCIENS Biopharma quarterly revenue?

The current quarterly revenue of CSCI is $1.87 M

What is the all time high quarterly revenue for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly revenue is $4.94 M

What is COSCIENS Biopharma quarterly revenue year-on-year change?

Over the past year, CSCI quarterly revenue has changed by +$538.30 K (+40.39%)

What is COSCIENS Biopharma TTM revenue?

The current TTM revenue of CSCI is $7.59 M

What is the all time high TTM revenue for COSCIENS Biopharma?

COSCIENS Biopharma all-time high TTM revenue is $15.56 M

What is COSCIENS Biopharma TTM revenue year-on-year change?

Over the past year, CSCI TTM revenue has changed by +$333.00 K (+4.59%)